Combination of CYP2C19 genotype with non-genetic factors evoking phenoconversion improves phenotype prediction, Pharmacol Rep, vol.70, issue.3, pp.525-557, 2018. ,
Inflammation is a major regulator of drug metabolizing enzymes and transporters: Consequences for the personalization of drug treatment, Pharmacol Ther, vol.215, p.107627, 2020. ,
COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome, Immunity, 2020. ,
Récepteurs de type Toll, réponse inflammatoire et sepsis. Réanimation, vol.13, pp.167-75, 2004. ,
Innate immunity: an overview, Mol Immunol, vol.40, issue.12, pp.845-59, 2004. ,
CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science, vol.249, pp.1431-1434, 1990. ,
Cytokines and macrophages, Biomed Pharmacother, vol.48, issue.10, pp.445-53, 1994. ,
Macrophages and Inflammatory Mediators in Tissue Injury, Annu Rev Pharmacol Toxicol, vol.35, issue.1, pp.655-77, 1995. ,
The role of interleukin-6 as the hepatocyte stimulating factor in the network of inflammatory cytokines, Ann N Y Acad Sci, vol.557, pp.1-8, 1989. ,
Molecular biology of inflammation and sepsis: a primer, Crit Care Med, vol.37, issue.1, pp.291-304, 2009. ,
, Cytokines in context. J Cell Biol, vol.113, issue.5, pp.981-987, 1991.
The cytokine network, Immunol Today, vol.10, issue.9, pp.299-304, 1989. ,
The acute phase response, Immunol Today, vol.15, issue.2, pp.74-80, 1994. ,
Interleukin-6 and the acute phase response, Biochem J, vol.265, issue.3, pp.621-657, 1990. ,
Initiation of acute phase response and synthesis of cytokines, Biochim Biophys Acta BBA -Mol Basis Dis, vol.1317, issue.2, pp.84-94, 1996. ,
Interleukin-6 signalling: more than Jaks and STATs, Eur J Cell Biol, vol.91, issue.6-7, pp.486-95, 2012. ,
The interleukin-1 family: back to the future. Immunity, vol.39, pp.1003-1021, 2013. ,
The liver in sepsis: patterns of response and injury, Curr Opin Crit Care, vol.19, issue.2, pp.123-130, 2013. ,
Acute-phase proteins and other systemic responses to inflammation, N Engl J Med, vol.340, issue.6, pp.448-54, 1999. ,
Rôle de la protéine C-réactive sur les sites d'inflammation et d'infection. Immunologie, vol.754, 2018. ,
Effect of lipopolysaccharide on the xenobiotic-induced expression and activity of hepatic cytochrome P450 in mice, Biol Pharm Bull, vol.35, issue.4, pp.473-80, 2012. ,
Regulation of drug-metabolizing enzymes and transporters in inflammation, Annu Rev Pharmacol Toxicol, vol.46, pp.123-172, 2006. ,
Regulation of Hepatic Cytochrome P450 Expression in Mice with Intestinal or Systemic Infections of Citrobacter rodentium, Drug Metab Dispos, vol.37, issue.2, pp.366-74, 2009. ,
Hepatic Cytochrome P450s, Phase II Enzymes and Nuclear Receptors Are Downregulated in a Th2 Environment during Schistosoma mansoni Infection, Drug Metab Dispos, vol.42, issue.1, pp.134-174, 2014. ,
A non-lethal malarial infection results in reduced drug metabolizing enzyme expression and drug clearance in mice, Malar J, vol.18, issue.1, p.234, 2019. ,
Modulation of Cytochrome P450 2A5 Activity by Lipopolysaccharide: Low-Dose Effects and Non-Monotonic Dose-Response Relationship, PLoS ONE, vol.10, issue.1, p.2532, 2015. ,
Hepatic and Renal Cytochrome P450 Gene Regulation During Citrobacter rodentium Infection in Wildtype and Toll-like Receptor 4 Mutant Mice, Drug Metab Dispos Biol Fate Chem, vol.34, issue.3, pp.354-60, 2006. ,
Down-regulation of human CYP3A4 by the inflammatory signal interleukin-6: molecular mechanism and transcription factors involved, FASEB J Off Publ Fed Am Soc Exp Biol, vol.16, issue.13, pp.1799-801, 2002. ,
Effects of Interleukin-6 (IL-6) and an Anti-IL-6 Monoclonal Antibody on Drug-Metabolizing Enzymes in Human Hepatocyte Culture, Drug Metab Dispos, vol.39, issue.8, pp.1415-1437, 2011. ,
Influence of inflammatory processes on ADME gene expression in human liver and hepatocytes. Poster presented at 17th North American Regional ISSX Meeting, 2011. ,
Selective effects of a therapeutic protein targeting tumor necrosis factor-alpha on cytochrome P450 regulation during infectious colitis: implications for disease-dependent drug-drug interactions, Pharmacol Res Perspect, vol.2, issue.1, pp.312-333, 2011. ,
Roles of Nitric Oxide in Inflammatory Down-Regulation of Human Cytochromes P450. Free Radic Biol Med, vol.44, pp.1161-1169, 2008. ,
Cytokines downregulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture, Mol Pharmacol, vol.44, issue.4, pp.707-722, 1993. ,
Effect of influenza immunization on CYP3A4 activity in vivo, J Clin Pharmacol, vol.43, issue.12, pp.1377-81, 2003. ,
Gene-Specific Effects of Inflammatory Cytokines on Cytochrome P4502C, 2B6 and 3A4 mRNA Levels in Human Hepatocytes, Drug Metab Dispos Biol Fate Chem, vol.35, issue.9, pp.1687-93, 2007. ,
Modulation of hepatic cytochrome P450s by Citrobacter rodentium infection in interleukin-6-and interferon-{gamma}-null mice, J Pharmacol Exp Ther, vol.335, issue.2, pp.480-488, 2010. ,
Hepatic cytochrome P450 downregulation during aseptic inflammation in the mouse is interleukin 6 dependent, Hepatol Baltim Md, vol.32, issue.1, pp.49-55, 2000. ,
Involvement of interleukin-6 and tumor necrosis factor alpha in CYP3A11 and 2C29 down-regulation by Bacillus Calmette-Guerin and lipopolysaccharide in mouse liver, Drug Metab Dispos Biol Fate Chem, vol.32, issue.7, pp.707-721, 2004. ,
Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR. Adv Drug Deliv Rev, vol.62, pp.1238-1287, 2010. ,
The involvement of the pregnane X receptor in hepatic gene regulation during inflammation in mice, J Pharmacol Exp Ther, vol.312, issue.2, pp.841-849, 2005. ,
Gene transcription in hepatocytes during the acute phase of a systemic inflammation: from transcription factors to target genes, Inflamm Res, vol.50, issue.8, pp.383-90, 2001. ,
Pregnane X receptor is required for interleukin-6 mediated down-regulation of cytochrome P450 3A4 in human hepatocytes, Toxicol Lett, vol.197, issue.3, pp.219-245, 2010. ,
Reduction in cytochrome P-450 enzyme expression is associated with repression of CAR (constitutive androstane receptor) and PXR (pregnane X receptor) in mouse liver during the acute phase response, Biochem Biophys Res Commun, vol.293, issue.1, pp.145-154, 2002. ,
Hepatic cytochrome P450 gene regulation during endotoxininduced inflammation in nuclear receptor knockout mice, J Pharmacol Exp Ther, vol.314, issue.2, pp.703-712, 2005. ,
Lipopolysaccharide and cecal ligation/puncture differentially affect the subcellular distribution of the pregnane X receptor but consistently cause suppression of its target genes CYP3A. Shock Augusta Ga, vol.19, pp.469-74, 2003. ,
Ah receptor and NF-kappaB interactions, a potential mechanism for dioxin toxicity, J Biol Chem, vol.274, issue.1, pp.510-515, 1999. ,
Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammation, J Clin Invest, vol.116, issue.8, pp.2280-2289, 2006. ,
Role of NF-kappaB in the regulation of cytochrome P450 enzymes, Curr Drug Metab, vol.10, issue.2, pp.164-78, 2009. ,
Transcriptional regulation of cytochrome p450 genes by the nuclear receptor hepatocyte nuclear factor 4-alpha, Curr Drug Metab, vol.10, issue.5, pp.508-527, 2009. ,
Regulation of the hepatic CYP 2E1 gene during chronic alcohol exposure: lack of an ethanol response element in the proximal 5'-flanking sequence, DNA Cell Biol, vol.16, issue.6, pp.725-761, 1997. ,
The effect of endotoxin on hepatocyte nuclear factor 1 nuclear protein binding: potential implications on CYP2E1 expression in the rat, J Pharm Pharmacol, vol.53, issue.10, pp.1365-71, 2001. ,
Inhibitory cross-talk between STAT5b and liver nuclear factor HNF3beta: impact on the regulation of growth hormone pulse-stimulated, male-specific liver cytochrome P-450 gene expression, J Biol Chem, vol.276, issue.46, pp.43031-43040, 2001. ,
Rapid Transcriptional Suppression of Rat Cytochrome P450 Genes by Endotoxin Treatment and Its Inhibition by Curcumin, J Pharmacol Exp Ther, vol.307, pp.1205-1217, 2004. ,
Roles of mitogen-activated protein kinases in the regulation of CYP genes, Curr Drug Metab, vol.11, issue.10, pp.850-858, 2010. ,
Extracellular Signal-Regulated Kinase Is an Endogenous Signal Retaining the Nuclear Constitutive Active/Androstane Receptor (CAR) in the Cytoplasm of Mouse Primary Hepatocytes, Mol Pharmacol, vol.71, issue.5, pp.1217-1238, 2007. ,
Coordinating Role of RXR? in Downregulating Hepatic Detoxification during Inflammation Revealed by Fuzzy-Logic Modeling, PLOS Comput Biol, vol.12, issue.1, p.1004431, 2016. ,
Cell Signaling and Nuclear Receptors: New Opportunities for Molecular Pharmaceuticals in Liver Disease, Mol Pharm, vol.5, issue.1, pp.17-34, 2008. ,
The JAK1/2 Inhibitor Ruxolitinib Reverses Interleukin-6-Mediated Suppression of Drug-Detoxifying Proteins in Cultured Human Hepatocytes, Drug Metab Dispos Biol Fate Chem, vol.46, issue.2, pp.131-171, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01699218
Role of nitric oxide in the cytokine-mediated regulation of cytochrome P-450, Mol Pharmacol, vol.49, issue.5, pp.796-801, 1996. ,
Nitric oxide-dependent proteasomal degradation of cytochrome P450 2B proteins, J Biol Chem, vol.283, issue.2, pp.889-98, 2008. ,
Dual mechanisms of CYP3A protein regulation by proinflammatory cytokine stimulation in primary hepatocyte cultures, Drug Metab Dispos Biol Fate Chem, vol.37, issue.4, pp.865-72, 2009. ,
Down-Regulation of Cytochrome P450 mRNAs and Proteins in Mice Lacking a Functional NOS2 Gene, Mol Pharmacol, vol.54, issue.2, pp.273-282, 1998. ,
Melatonin attenuates lipopolysaccharideinduced down-regulation of pregnane X receptor and its target gene CYP3A in mouse liver, J Pineal Res, vol.38, issue.1, pp.27-34, 2005. ,
Kupffer cells and reactive oxygen species partially mediate lipopolysaccharide-induced downregulation of nuclear receptor pregnane x receptor and its target gene CYP3a in mouse liver, Free Radic Biol Med, vol.37, issue.1, pp.10-22, 2004. ,
Nitric oxide and interleukin-1? stimulate the proteasome-independent degradation of the retinoic acid hydroxylase CYP2C22 in primary rat hepatocytes, J Pharmacol Exp Ther, vol.348, issue.1, pp.141-52, 2014. ,
Nitric oxide-regulated proteolysis of human CYP2B6 via the ubiquitin-proteasome system, Free Radic Biol Med, vol.108, pp.478-86, 2017. ,
Contribution of hepatocyte nuclear factor-4 to down-regulation of CYP2D6 gene expression by nitric oxide, Mol Pharmacol, vol.61, issue.1, pp.194-200, 2002. ,
Down-regulation of nuclear receptor DNA-binding activity by nitric oxide--HNF4 as a model system, Med Sci Monit Int Med J Exp Clin Res, vol.8, issue.10, pp.217-220, 2002. ,
Association of DNA Methylation with Acute Mania and Inflammatory Markers, PloS One, vol.10, issue.7, p.132001, 2015. ,
Noncoding microRNAs: small RNAs play a big role in regulation of ADME?, Acta Pharm Sin B, vol.2, issue.2, pp.93-101, 2012. ,
microRNAs as mediators of drug toxicity, Annu Rev Pharmacol Toxicol, vol.53, pp.377-400, 2013. ,
microRNA-34a is associated with expression of key hepatic transcription factors and cytochromes P450, Biochem Biophys Res Commun, vol.445, issue.2, pp.404-415, 2014. ,
Expression variability of absorption, distribution, metabolism, excretion-related microRNAs in human liver: influence of nongenetic factors and association with gene expression, Drug Metab Dispos Biol Fate Chem, vol.41, issue.10, pp.1752-62, 2013. ,
Inflammation-associated microRNA-130b down-regulates cytochrome P450 activities and directly targets CYP2C9, Drug Metab Dispos Biol Fate Chem, vol.43, issue.6, pp.884-892, 2015. ,
MicroRNA hsa-miR-370-3p suppresses the expression and induction of CYP2D6 by facilitating mRNA degradation, Biochem Pharmacol, vol.140, pp.139-188, 2017. ,
Expression, function and regulation of mouse cytochrome P450 enzymes: comparison with human P450 enzymes, Curr Drug Metab, vol.10, issue.10, pp.1151-83, 2009. ,
Serum C-reactive protein levels affect the plasma voriconazole trough levels in allogeneic hematopoietic cell transplant recipients. Leuk Lymphoma, vol.58, pp.2731-2734, 2017. ,
Inflammation is a potential risk factor of voriconazole overdose in hematological patients, Fundam Clin Pharmacol, vol.33, issue.2, pp.232-240, 2019. ,
Longitudinal Analysis of the Effect of Inflammation on Voriconazole Trough Concentrations, Antimicrob Agents Chemother, vol.60, issue.5, pp.2727-2758, 2016. ,
Inflammation Is Associated with Voriconazole Trough Concentrations, Antimicrob Agents Chemother, vol.58, issue.12, pp.7098-101, 2014. ,
Influence of inflammation on voriconazole metabolism, Antimicrob Agents Chemother, vol.59, issue.5, pp.2942-2945, 2015. ,
Voriconazole metabolism is influenced by severe inflammation: a prospective study, J Antimicrob Chemother, vol.72, issue.1, pp.261-268, 2017. ,
Impact of inflammation and concomitant glucocorticoid administration on plasma concentration of triazole antifungals in immunocompromised patients, Clin Chim Acta, vol.441, pp.127-159, 2015. ,
Relationship Between the CYP2C19 Phenotype Using the Voriconazole-to-Voriconazole N-Oxide Plasma Concentration Ratio and Demographic and Clinical Characteristics of Japanese Patients With Different CYP2C19 Genotypes, Ther Drug Monit, vol.39, issue.5, pp.514-535, 2017. ,
Moderate correlation between systemic IL-6 responses and CRP with trough concentrations of voriconazole, Br J Clin Pharmacol, vol.84, issue.9, pp.1980-1988, 2018. ,
The Influence of Proinflammatory Cytokines on Voriconazole Trough Concentration in Patients With Different Forms of Hematologic Disorders, J Clin Pharmacol, vol.59, issue.10, pp.1340-50, 2019. ,
Posaconazole trough concentrations are not influenced by inflammation: A prospective study, Int J Antimicrob Agents, vol.53, issue.3, pp.325-334, 2019. ,
Serious respiratory infections can increase clozapine levels and contribute to side effects: a case report, Prog Neuropsychopharmacol Biol Psychiatry, vol.27, issue.6, pp.1059-63, 2003. ,
Toxic rise of clozapine plasma concentrations in relation to inflammation, Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol, vol.13, issue.5, pp.381-386, 2003. ,
Toxic clozapine serum levels during acute urinary tract infection: a case report, Eur J Clin Pharmacol, vol.60, issue.12, pp.909-919, 2005. ,
Two cases of high serum clozapine concentrations occurring during inflammation in Chinese patients, Int J Psychiatry Med, vol.53, issue.4, pp.292-305, 2018. ,
Toxic clozapine serum levels during inflammatory reactions, J Clin Psychopharmacol, vol.29, issue.4, pp.392-396, 2009. ,
Inflammation and psychotropic drugs: the relationship between C-reactive protein and antipsychotic drug levels, Psychopharmacology (Berl), vol.233, issue.9, pp.1695-705, 2016. ,
A puzzling case of increased serum clozapine levels in a patient with inflammation and infection, Ther Drug Monit, vol.34, issue.5, pp.489-92, 2012. ,
Systemic Inflammation Complicates the Interpretation of Therapeutic Drug Monitoring of Risperidone, J Clin Psychopharmacol, vol.38, issue.3, pp.263-268, 2018. ,
Influence of Inflammation on the Pharmacokinetics of Perampanel, Ther Drug Monit, vol.40, issue.6, pp.725-734, 2018. ,
Inflammation and Organ Failure Severely Affect Midazolam Clearance in Critically Ill Children, Am J Respir Crit Care Med, vol.194, issue.1, pp.58-66, 2016. ,
Population pharmacodynamic modelling of midazolam induced sedation in terminally ill adult patients, Br J Clin Pharmacol, vol.84, issue.2, pp.320-350, 2018. ,
Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients, Br J Clin Pharmacol, vol.57, issue.2, pp.135-180, 2004. ,
, Pharmacokinetics and Toxicity of Tacrolimus Early After Heart and Lung Transplantation
, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.15, issue.9, pp.2301-2314, 2015.
Effects of elevated tacrolimus trough levels in association with infectious enteritis on graft function in renal transplant recipients, Transplant Proc, vol.46, issue.2, pp.592-596, 2014. ,
Severe elevations of FK506 blood concentration due to diarrhea in renal transplant recipients, Clin Transplant, vol.18, issue.5, pp.585-90, 2004. ,
Cytochrome P450 3A4 and P-glycoprotein activity and assimilation of tacrolimus in transplant patients with persistent diarrhea, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.5, issue.6, pp.1383-91, 2005. ,
Elevated blood concentrations of calcineurin inhibitors during diarrheal episode in pediatric liver transplant recipients: involvement of the suppression of intestinal cytochrome P450 3A and P-glycoprotein, Pediatr Transplant, vol.9, issue.3, pp.315-338, 2005. ,
Unexpected overdose blood concentration of tacrolimus: Keep in mind the role of inflammation, Br J Clin Pharmacol ,
,
High Variability of Whole-Blood Tacrolimus Pharmacokinetics Early After Thoracic Organ Transplantation, Eur J Drug Metab Pharmacokinet, vol.45, issue.1, pp.123-157, 2020. ,
High Intrapatient Variability of Tacrolimus Exposure in the Early Period After Liver Transplantation Is Associated With Poorer Outcomes, Transplantation, vol.102, issue.3, pp.108-122, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02454671
Acute-phase response, interleukin-6, and alteration of cyclosporine pharmacokinetics, Clin Pharmacol Ther, vol.55, issue.6, pp.649-60, 1994. ,
Significant effect of infection and food intake on sirolimus pharmacokinetics and exposure in pediatric patients with acute lymphoblastic leukemia, Eur J Pharm Sci, vol.128, pp.209-223, 2019. ,
Altered theophylline pharmacokinetics during acute respiratory viral illness, Lancet Lond Engl, vol.1, issue.8074, pp.1132-1135, 1978. ,
Altered Theophylline Clearance During an Influenza B Outbreak, Pediatrics, vol.69, issue.4, pp.476-80, 1982. ,
INHIBITION OF THEOPHYLLINE METABOLISM BY INTERFERON. The Lancet, vol.330, pp.939-980, 1987. ,
Physiological Regulation of Drug Metabolism and Transport: Pregnancy, Microbiome, Inflammation, Infection, and Fasting, Drug Metab Dispos, vol.46, issue.5, pp.503-516, 2018. ,
Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug-Drug Interactions, Ther Drug Monit ,
URL : https://hal.archives-ouvertes.fr/hal-02563361
The pathogenesis and treatment of the `Cytokine Storm' in COVID-19, J Infect, vol.80, issue.6, pp.607-620, 2020. ,
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, vol.395, pp.497-506, 2020. ,
Induction of proinflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies, J Biol Regul Homeost Agents, vol.34, issue.2, 202014. ,
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19, N Engl J Med, vol.382, issue.19, pp.1787-99, 2020. ,
Pharmacokinetics of Lopinavir and Ritonavir in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19), Ann Intern Med, 2020. ,
Pharmacokinetics of lopinavir/ritonavir oral solution to treat COVID-19 in mechanically ventilated ICU patients, J Antimicrob Chemother, 2020. ,
Immune Activation Mediated Change in Alpha-1-Acid Glycoprotein: Impact on Total and Free Lopinavir Plasma Exposure, J Clin Pharmacol, vol.51, issue.11, pp.1539-1587, 2011. ,
Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro, Antiviral Res, vol.178, p.104786, 2020. ,
Severe COVID-19 in a renal transplant recipient: A focus on pharmacokinetics, Am J Transplant, 2020. ,
Direct oral anticoagulant plasma levels' striking increase in severe COVID-19 respiratory syndrome patients treated with antiviral agents: The Cremona experience, J Thromb Haemost, 2020. ,
Clozapine is strongly associated with the risk of pneumonia and inflammation, Gen Psychiatry, vol.33, issue.2, 2020. ,
URL : https://hal.archives-ouvertes.fr/inserm-02632133
COVID-19 Infection May Cause Clozapine Intoxication: Case Report and Discussion, 2020. ,
Neuroleptic malignant syndrome in a COVID-19 patient, Brain Behav Immun, vol.88, pp.28-37, 2020. ,